Key result
Tricuspid regurgitation regression after M-TEER linked to ~67% lower mortality.
Why the study?
Improvement in concomitant tricuspid regurgitation after M-TEER for mitral regurgitation occurs frequently, but factors determining the post-procedural course of tricuspid regurgitation are not well understood.
What are the predictors of improvement in concomitant tricuspid regurgitation following transcatheter edge-to-edge mitral valve repair?
Cohort (n=300)
What are the predictors of improvement in concomitant tricuspid regurgitation following transcatheter edge-to-edge mitral valve repair?
Effect estimate: HR 0.333 (95% CI 0.112-0.996)
p-value: p=0.049
Improvement in concomitant tricuspid regurgitation after M-TEER is predicted by female sex and higher baseline MR/TR grades, and is associated with improved survival.
Background: Improvement in concomitant tricuspid regurgitation (TR) after mitral valve transcatheter edge-to-edge repair (M-TEER) for mitral regurgitation (MR) occurs frequently; however factors determining the post-procedural course of TR are not well understood. We investigated the parameters associated with TR improvement after M-TEER. Methods and Results: A total of 300 patients were consecutively included in this retrospective analysis. MR and TR severity as well as heart chamber metrics were assessed before the procedure and at follow-up. Device success was achieved in 97.3% of patients. TR decreased in 30.2% of patients. Patients with improved TR were more often female, had more severe TR at baseline, and their right heart dimensions at baseline trended to be smaller. Female sex (odds ratio (OR) 2.997), baseline MR-Grade (OR 3.181) and baseline TR-Grade (OR 2.653) independently predicted TR reduction. More pronounced right heart reverse remodeling was observed in patients with improved TR. TR regression independently predicted lower mortality (hazard ratio (HR) 0.333, 95% confidence interval 0.112–0.996, p = 0.049). Conclusions: A reduction in concomitant TR severity after M-TEER occurred mainly in females and in patients with high-grade TR and MR at baseline. TR regression is associated with better survival after M-TEER.
No takes yet. Share an insight, caveat, or question.
Gröger et al. (2023) conducted a cohort in Mitral regurgitation with concomitant tricuspid regurgitation (n=300). Mitral valve transcatheter edge-to-edge repair (M-TEER) was evaluated on Mortality (HR 0.333, 95% CI 0.112-0.996, p=0.049). Tricuspid regurgitation regression after M-TEER occurred in 30.2% of patients and independently predicted lower mortality (HR 0.333; 95% CI 0.112-0.996; p=0.049).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: